Ellipsys Medical, Inc. has an exempt securities offering totaling $10,850,000, with $5,906,665 already sold. The disclosed figures give investors the stated size of the Capital raise, the amount completed, and the remaining $4,943,335 associated with the offering.

Key Highlights

  • The record dated September 16, 2026, identifies Frank Hettmann as president.
  • The offering data lists $4,943,335 as the remaining amount.
  • Ellipsys Medical, Inc. is identified as a Delaware corporation in the healthcare sector.

Ellipsys Medical, Inc. has an exempt securities offering totaling $10,850,000, with $5,906,665 already sold. The disclosed figures leave $4,943,335 associated with the offering after the reported sales.

Offering Figures and Named Directors

The record is dated September 16, 2026. Frank Hettmann is listed as president. Ed Chang, Mark Ritchart, Steve Parker, Jeffrey Hull and Brian Driscoll are identified as directors. The notice also identifies Frank Hettmann at the San Clemente address. The offering is classified under 06b. The reported amount sold is $5,906,665, while the offering amount is $10,850,000 and the associated remaining amount is $4,943,335.